{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:16Z","timestamp":1793727736153,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Zielsetzung<\/jats:title>\n                <jats:p>Es erfolgt eine aktualisierte Sch\u00e4tzung der Pr\u00e4valenz entz\u00fcndlich rheumatischer Erkrankungen (ERE) in Deutschland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodik<\/jats:title>\n                <jats:p>Mit einer systematischen Literaturrecherche in PubMed und Web of Science (letzte Suche am 08.11.2022) wurden Originalartikel (regionale und bundesweite Surveys und Routinedatenanalysen f\u00fcr Arthritiden, Kollagenosen und Vaskulitiden) zur Pr\u00e4valenz von ERE f\u00fcr den Zeitraum 2014 bis 2022 identifiziert. Datenquellen, Erhebungszeitraum, Diagnosedefinition und das Risiko einer Verzerrung werden berichtet. Die Pr\u00e4valenzen wurden anhand der verf\u00fcgbaren Daten unter Ber\u00fccksichtigung internationaler Angaben gesch\u00e4tzt.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Die Suche durch 2\u00a0Autorinnen ergab 263\u00a0Treffer, von denen 18\u00a0Routinedatenanalysen und 2\u00a0Surveys die Einschlusskriterien erf\u00fcllten. Die Pr\u00e4valenzangaben lagen bei 0,42\u20131,85\u202f% (rheumatoide Arthritis), 0,32\u20130,5\u202f% (ankylosierende Spondylitis), 0,11\u20130,32\u202f% (Psoriasisarthritis), 0,037\u20130,14\u202f% (systemischer Lupus erythematodes), 0,07\u20130,77\u202f% (Sj\u00f6gren\/Sicca-Syndrom), 0,14\u20130,15\u202f% (Polymyalgia rheumatica, ab 40\u00a0Jahre), 0,04\u20130,05\u202f% (Riesenzellarteriitis, ab 50\u00a0Jahre) und 0,015\u20130,026\u202f% (ANCA-assoziierte Vaskulitis). Das Bias-Risiko war in 13\u00a0Studien moderat, in 7\u00a0Studien hoch. Anhand dieser Ergebnisse sch\u00e4tzen wir die Pr\u00e4valenz von ERE in Deutschland auf 2,2\u20133,0\u202f%. Dies entspricht in etwa 1,5 bis 2,1\u202fMio. Betroffenen. Die Pr\u00e4valenz der juvenilen idiopathischen Arthritis wurde mit ca.\u00a00,10\u202f% (0,07\u20130,13\u202f%) der 0\u2011 bis 18-J\u00e4hrigen angegeben, was etwa 14.000\u00a0Kindern und Jugendlichen in Deutschland entspricht.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Dieses systematische Review zeigt einen Anstieg der Pr\u00e4valenzen von ERE in Deutschland, basiert jedoch fast ausschlie\u00dflich auf Routinedatenanalysen. In Ermangelung mehrstufiger Bev\u00f6lkerungsstudien sind die vorliegenden Daten bei moderat bis hohem Verzerrungsrisiko insgesamt unsichere Quellen f\u00fcr Pr\u00e4valenzsch\u00e4tzungen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00393-022-01305-2","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:03:16Z","timestamp":1672668196000},"page":"727-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Systematisches Review zur Sch\u00e4tzung der Pr\u00e4valenz entz\u00fcndlich rheumatischer Erkrankungen in Deutschland","Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version"],"prefix":"10.1007","volume":"82","author":[{"given":"Katinka","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Minden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Regierer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Strangfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Callhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"issue":"4","key":"1305_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s00393-016-0094-2","volume":"75","author":"A Zink","year":"2016","unstructured":"Zink\u00a0A, Albrecht\u00a0K (2016) How frequent are musculoskeletal diseases in Germany? Z\u00a0Rheumatol 75(4):346\u2013353. https:\/\/doi.org\/10.1007\/s00393-016-0094-2","journal-title":"Z Rheumatol"},{"issue":"9","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy\u00a0D, Brooks\u00a0P, Woolf\u00a0A, Blyth\u00a0F, March\u00a0L, Bain\u00a0C, Baker\u00a0P, Smith\u00a0E, Buchbinder\u00a0R (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J\u00a0Clin Epidemiol 65(9):934\u2013939. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.11.014","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page\u00a0MJ, McKenzie\u00a0JE, Bossuyt\u00a0PM, Boutron\u00a0I, Hoffmann\u00a0TC, Mulrow\u00a0CD, Shamseer\u00a0L, Tetzlaff\u00a0JM, Akl\u00a0EA, Brennan\u00a0SE, Chou\u00a0R, Glanville\u00a0J, Grimshaw\u00a0JM, Hrobjartsson\u00a0A, Lalu\u00a0MM, Li\u00a0T, Loder\u00a0EW, Mayo-Wilson\u00a0E, McDonald\u00a0S, McGuinness\u00a0LA, Stewart\u00a0LA, Thomas\u00a0J, Tricco\u00a0AC, Welch\u00a0VA, Whiting\u00a0P, Moher\u00a0D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"issue":"4","key":"1305_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00103-020-03110-1","volume":"63","author":"CO Schmidt","year":"2020","unstructured":"Schmidt\u00a0CO, Gunther\u00a0KP, Goronzy\u00a0J, Albrecht\u00a0K, Chenot\u00a0JF, Callhoff\u00a0J, Richter\u00a0A, Kasch\u00a0R, Ahrens\u00a0W, Becher\u00a0H, Berger\u00a0K, Brenner\u00a0H, Fischer\u00a0B, Franzke\u00a0CW, Hoffmann\u00a0W, Holleczek\u00a0B, Jaeschke\u00a0L, Jenning\u00a0C, Jockel\u00a0KH, Kaaks\u00a0R, Keil\u00a0T, Kluttig\u00a0A, Krause\u00a0G, Kuss\u00a0O, Leitzmann\u00a0M, Lieb\u00a0W, Linseisen\u00a0J, Loffler\u00a0M, Meinke-Franze\u00a0C, Meisinger\u00a0C, Michels\u00a0KB, Mikolajczyk\u00a0R, Obi\u00a0N, Peters\u00a0A, Pischon\u00a0T, Schikowski\u00a0T, Schipf\u00a0S, Specker\u00a0C, Volzke\u00a0H, Wirkner\u00a0K, Zink\u00a0A, Sander\u00a0O (2020) Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 63(4):415\u2013425. https:\/\/doi.org\/10.1007\/s00103-020-03110-1","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"5","key":"1305_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/a-1192-4628","volume":"83","author":"C Kienitz","year":"2021","unstructured":"Kienitz\u00a0C, Grellmann\u00a0C, Hapfelmeier\u00a0J (2021) Prevalence of rheumatoid arthritis in Germany: analysis of longitudinal data of statutory health insurance. Gesundheitswesen 83(5):367\u2013373. https:\/\/doi.org\/10.1055\/a-1192-4628","journal-title":"Gesundheitswesen"},{"issue":"1","key":"1305_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12325-020-01522-8","volume":"38","author":"C Grellmann","year":"2021","unstructured":"Grellmann\u00a0C, Dombrowsky\u00a0W, Fabricius\u00a0V, Suruki\u00a0R, Sheahan\u00a0A, Joeres\u00a0L (2021) Epidemiology and treatment of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in Germany: a real-world evidence study. Adv Ther 38(1):366\u2013385. https:\/\/doi.org\/10.1007\/s12325-020-01522-8","journal-title":"Adv Ther"},{"issue":"2","key":"1305_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00393-017-0381-6","volume":"77","author":"A Strahl","year":"2018","unstructured":"Strahl\u00a0A, Schneider\u00a0O, Frankenhauser-Mannuss\u00a0J, Knapstein\u00a0S, Hermann\u00a0C, Lembeck\u00a0B, Lorenz\u00a0HM, Ruther\u00a0W, Flechtenmacher\u00a0J (2018) Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis\u2014Insurance data on outpatient and inpatient care in Baden-Wurttemberg. Z\u00a0Rheumatol 77(2):113\u2013126. https:\/\/doi.org\/10.1007\/s00393-017-0381-6","journal-title":"Z Rheumatol"},{"key":"1305_CR8","doi-asserted-by":"publisher","DOI":"10.20364\/VA-17.08","volume-title":"Epidemiologie der rheumatoiden Arthritis in Deutschland \u2013 eine Analyse anhand bundesweiter vertrags\u00e4rztlicher Abrechnungsdaten","author":"A Steffen","year":"2017","unstructured":"Steffen\u00a0A, Holstiege\u00a0J, Goffrier\u00a0B, B\u00e4tzing\u00a0J (2017) Epidemiologie der rheumatoiden Arthritis in Deutschland \u2013 eine Analyse anhand bundesweiter vertrags\u00e4rztlicher Abrechnungsdaten https:\/\/doi.org\/10.20364\/VA-17.08 (versorgungsatlas.de, Bericht Nr.\u00a017\/08, ver\u00f6ffentlicht am 23.11.2017)"},{"issue":"8","key":"1305_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00393-016-0088-0","volume":"75","author":"S Hense","year":"2016","unstructured":"Hense\u00a0S, Luque Ramos\u00a0A, Callhoff\u00a0J, Albrecht\u00a0K, Zink\u00a0A, Hoffmann\u00a0F (2016) Prevalence of rheumatoid arthritis in Germany based on health insurance data : regional differences and first results of the PROCLAIR study. Z\u00a0Rheumatol 75(8):819\u2013827. https:\/\/doi.org\/10.1007\/s00393-016-0088-0","journal-title":"Z Rheumatol"},{"issue":"11","key":"1305_CR10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00296-018-4124-z","volume":"38","author":"K Kr\u00fcger","year":"2018","unstructured":"Kr\u00fcger\u00a0K, von Hinuber\u00a0U, Meier\u00a0F, Tian\u00a0H, Bohm\u00a0K, Jugl\u00a0SM, Borchert\u00a0K, Meise\u00a0D, Konig\u00a0C, Braun\u00a0S (2018) Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a\u00a0German claims database analysis. Rheumatol Int 38(11):2121\u20132131. https:\/\/doi.org\/10.1007\/s00296-018-4124-z","journal-title":"Rheumatol Int"},{"key":"1305_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001975","author":"M Deike","year":"2021","unstructured":"Deike\u00a0M, Brinks\u00a0R, Meller\u00a0S, Schneider\u00a0M, Sewerin\u00a0P (2021) Risk of psoriatic arthritis depending on age: analysis of data from 65\u00a0million people on statutory insurance in Germany. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2021-001975","journal-title":"RMD Open"},{"issue":"2","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/annrheumdis-2018-214065","volume":"78","author":"P Sewerin","year":"2019","unstructured":"Sewerin\u00a0P, Brinks\u00a0R, Schneider\u00a0M, Haase\u00a0I, Vordenbaumen\u00a0S (2019) Prevalence and incidence of psoriasis and psoriatic arthritis. Ann Rheum Dis 78(2):286\u2013287. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214065","journal-title":"Ann Rheum Dis"},{"key":"1305_CR13","doi-asserted-by":"publisher","first-page":"adv00566","DOI":"10.2340\/00015555-3879","volume":"101","author":"M Reinhardt","year":"2021","unstructured":"Reinhardt\u00a0M, Garbe\u00a0C, Peterson\u00a0J, Augustin\u00a0M, Kirsten\u00a0N, Biermann\u00a0M, H\u00e4berle\u00a0B, Hagenstr\u00f6m\u00a0A (2021) Epidemiology, comorbidity and risk factors for psoriatic arthritis: a health insurance claims database analysis. Acta Derm Venereol 101:adv566","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/ddg.13464","volume":"16","author":"W Sondermann","year":"2018","unstructured":"Sondermann\u00a0W, Ventzke\u00a0J, Matusiewicz\u00a0D, Korber\u00a0A (2018) Analysis of pharmaceutical care in patients with psoriatic arthritis using statutory health insurance data. J\u00a0Dtsch Dermatol Ges 16(3):285\u2013294. https:\/\/doi.org\/10.1111\/ddg.13464","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"1305_CR15","doi-asserted-by":"publisher","first-page":"rkaa033","DOI":"10.1093\/rap\/rkaa033","volume":"4","author":"J Rech","year":"2020","unstructured":"Rech\u00a0J, Sticherling\u00a0M, Stoessel\u00a0D, Biermann\u00a0MHC, Haberle\u00a0BM, Reinhardt\u00a0M (2020) Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a\u00a0claims database analysis. Rheumatol Adv Pract 4(2):rkaa33. https:\/\/doi.org\/10.1093\/rap\/rkaa033","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"1305_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s40744-021-00277-0","volume":"8","author":"A Schwarting","year":"2021","unstructured":"Schwarting\u00a0A, Friedel\u00a0H, Garal-Pantaler\u00a0E, Pignot\u00a0M, Wang\u00a0X, Nab\u00a0H, Desta\u00a0B, Hammond\u00a0ER (2021) The burden of systemic lupus erythematosus in Germany: incidence, prevalence, and healthcare resource utilization. Rheumatol Ther 8(1):375\u2013393. https:\/\/doi.org\/10.1007\/s40744-021-00277-0","journal-title":"Rheumatol Ther"},{"issue":"13","key":"1305_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1177\/0961203314540352","volume":"23","author":"R Brinks","year":"2014","unstructured":"Brinks\u00a0R, Fischer-Betz\u00a0R, Sander\u00a0O, Richter\u00a0JG, Chehab\u00a0G, Schneider\u00a0M (2014) Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030. Lupus 23(13):1407\u20131411. https:\/\/doi.org\/10.1177\/0961203314540352","journal-title":"Lupus"},{"issue":"4","key":"1305_CR18","first-page":"78","volume":"126","author":"K Albrecht","year":"2020","unstructured":"Albrecht\u00a0K, Dorner\u00a0T, Redeker\u00a0I, Karberg\u00a0K, Marschall\u00a0U, Zink\u00a0A, Callhoff\u00a0J (2020) Comorbidity and health care utilisation in persons with Sjogren\u2019s syndrome: a\u00a0claims data analysis. Clin Exp Rheumatol 126(4):78\u201384","journal-title":"Clin Exp Rheumatol"},{"issue":"24","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3238\/arztebl.m2022.0218","volume":"119","author":"MG Colombo","year":"2022","unstructured":"Colombo\u00a0MG, Wetzel\u00a0AJ, Haumann\u00a0H, Dally\u00a0S, Kirtschig\u00a0G, Joos\u00a0S (2022) Polymyalgia rheumatica. Dtsch Arztebl Int 119(24):411\u2013417. https:\/\/doi.org\/10.3238\/arztebl.m2022.0218","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/rheumatology\/ket440","volume":"53","author":"K Herlyn","year":"2014","unstructured":"Herlyn\u00a0K, Buckert\u00a0F, Gross\u00a0WL, Reinhold-Keller\u00a0E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology 53(5):882\u2013889. https:\/\/doi.org\/10.1093\/rheumatology\/ket440","journal-title":"Rheumatology"},{"issue":"10","key":"1305_CR21","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1093\/rheumatology\/keaa924","volume":"60","author":"B Hellmich","year":"2021","unstructured":"Hellmich\u00a0B, Lamprecht\u00a0P, Spearpoint\u00a0P, Gotte\u00a0D, Deichmann\u00a0A, Buchholz\u00a0I, Schonermark\u00a0MP, Rutherford\u00a0P (2021) New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a\u00a0claims data study. Rheumatology 60(10):4868\u20134873. https:\/\/doi.org\/10.1093\/rheumatology\/keaa924","journal-title":"Rheumatology"},{"key":"1305_CR22","unstructured":"Thomschke S et al (2018) Epidemiologie der juvenilen idiopathischen Arthritis (JIA) in der ambulanten Versorgung \u2013 eine Analyse anhand bundesweiter vertrags\u00e4rztlicher Abrechnungsdaten der Jahre 2009 bis 2015. https:\/\/www.versorgungsatlas.de\/themen\/alle-analysen-nach-datum-sortiert\/?tab=6&uid=96 (Versorgungsatlas-Bericht Nr 18\/10). Zugegriffen: 19. Okt. 2022"},{"issue":"2","key":"1305_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.semarthrit.2017.05.003","volume":"47","author":"A Luque Ramos","year":"2017","unstructured":"Luque Ramos\u00a0A, Hoffmann\u00a0F, Albrecht\u00a0K, Klotsche\u00a0J, Zink\u00a0A, Minden\u00a0K (2017) Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis. Semin Arthritis Rheum 47(2):269\u2013275. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.003","journal-title":"Semin Arthritis Rheum"},{"key":"1305_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5562","author":"J Callhoff","year":"2022","unstructured":"Callhoff\u00a0J, Albrecht\u00a0K, Marschall\u00a0U, Strangfeld\u00a0A, Hoffmann\u00a0F (2022) Identification of rheumatoid arthritis in German claims data using different algorithms: validation by cross-sectional patient-reported survey data. Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.5562","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1305_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00393-022-01192-7","volume":"81","author":"K Albrecht","year":"2022","unstructured":"Albrecht\u00a0K, Callhoff\u00a0J, Strangfeld\u00a0A (2022) Is the prevalence of rheumatoid arthritis truly on the rise? Z\u00a0Rheumatol 81(4):323\u2013327. https:\/\/doi.org\/10.1007\/s00393-022-01192-7","journal-title":"Z Rheumatol"},{"key":"1305_CR26","unstructured":"Statistisches Bundesamt (2022) Bev\u00f6lkerung nach Altersgruppen (ab 2011). https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Bevoelkerung\/Bevoelkerungsstand\/Tabellen\/liste-altersgruppen.html#474508. Zugegriffen: 14. Okt. 2022"},{"issue":"2","key":"1305_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00393-021-00971-y","volume":"80","author":"K Albrecht","year":"2021","unstructured":"Albrecht\u00a0K, Marschall\u00a0U, Callhoff\u00a0J (2021) Prescription of analgesics in patients with rheumatic diseases in Germany : a claims data analysis. Z\u00a0Rheumatol 80(2):68\u201375. https:\/\/doi.org\/10.1007\/s00393-021-00971-y","journal-title":"Z Rheumatol"},{"key":"1305_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2021.1997436","author":"AM Kerola","year":"2022","unstructured":"Kerola\u00a0AM, Rollefstad\u00a0S, Kazemi\u00a0A, Wibetoe\u00a0G, Sexton\u00a0J, Mars\u00a0N, Kauppi\u00a0M, Kvien\u00a0TK, Haavardsholm\u00a0EA, Semb\u00a0AG (2022) Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol. https:\/\/doi.org\/10.1080\/03009742.2021.1997436","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"1305_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00393-019-0619-6","volume":"78","author":"J Braun","year":"2019","unstructured":"Braun\u00a0J, Schwarting\u00a0A, Hammel\u00a0L, Legeler\u00a0C, Wimmer\u00a0P, Farber\u00a0L, Behrens\u00a0F (2019) Medical care situation of patients with ankylosing spondylitis and psoriatic arthritis in Germany : medical care situation of patients with spondyloarthritis (spA): ankylosing spondylitis (AS) and psoriatic arthritis (PsA) from the perspective of rheumatologists in private practice and hospitals in Germany-results of the research project \u201cspA loop-life of outpatients\u201d. Z\u00a0Rheumatol 78(4):372\u2013381. https:\/\/doi.org\/10.1007\/s00393-019-0619-6","journal-title":"Z Rheumatol"},{"issue":"6","key":"1305_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/maj.0b013e318294457f","volume":"345","author":"JD Reveille","year":"2013","unstructured":"Reveille\u00a0JD, Weisman\u00a0MH (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345(6):431\u2013436. https:\/\/doi.org\/10.1097\/maj.0b013e318294457f","journal-title":"Am J Med Sci"},{"issue":"1","key":"1305_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semarthrit.2018.01.003","volume":"48","author":"L Scotti","year":"2018","unstructured":"Scotti\u00a0L, Franchi\u00a0M, Marchesoni\u00a0A, Corrao\u00a0G (2018) Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 48(1):28\u201334. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.003","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1305_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1468-3083.2009.03159.x","volume":"23","author":"MA Radtke","year":"2009","unstructured":"Radtke\u00a0MA, Reich\u00a0K, Blome\u00a0C, Rustenbach\u00a0S, Augustin\u00a0M (2009) Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009\u00a0patients with psoriasis: results of a\u00a0German national survey. J\u00a0Eur Acad Dermatol Venereol 23(6):683\u2013691. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03159.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1305_CR33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/j.1365-2133.2008.09023.x","volume":"160","author":"K Reich","year":"2009","unstructured":"Reich\u00a0K, Kruger\u00a0K, Mossner\u00a0R, Augustin\u00a0M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a\u00a0prospective interdisciplinary epidemiological study of 1511\u00a0patients with plaque-type psoriasis. Br J Dermatol 160(5):1040\u20131047. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.09023.x","journal-title":"Br J Dermatol"},{"issue":"2","key":"1305_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00296-013-2876-z","volume":"34","author":"JC Henes","year":"2014","unstructured":"Henes\u00a0JC, Ziupa\u00a0E, Eisfelder\u00a0M, Adamczyk\u00a0A, Knaudt\u00a0B, Jacobs\u00a0F, Lux\u00a0J, Schanz\u00a0S, Fierlbeck\u00a0G, Spira\u00a0D, Horger\u00a0M, Kanz\u00a0L, Koetter\u00a0I (2014) High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a\u00a0cross-sectional study. Rheumatol Int 34(2):227\u2013234. https:\/\/doi.org\/10.1007\/s00296-013-2876-z","journal-title":"Rheumatol Int"},{"issue":"11","key":"1305_CR35","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees\u00a0F, Doherty\u00a0M, Grainge\u00a0MJ, Lanyon\u00a0P, Zhang\u00a0W (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a\u00a0systematic review of epidemiological studies. Rheumatology 56(11):1945\u20131961. https:\/\/doi.org\/10.1093\/rheumatology\/kex260","journal-title":"Rheumatology"},{"issue":"1","key":"1305_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","volume":"75","author":"F Rees","year":"2016","unstructured":"Rees\u00a0F, Doherty\u00a0M, Grainge\u00a0M, Davenport\u00a0G, Lanyon\u00a0P, Zhang\u00a0W (2016) The incidence and prevalence of systemic lupus erythematosus in the UK, 1999\u20132012. Ann Rheum Dis 75(1):136\u2013141. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206334","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1305_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00393-009-0518-3","volume":"69","author":"G Westhoff","year":"2010","unstructured":"Westhoff\u00a0G, Zink\u00a0A (2010) Epidemiology of primary Sjorgren\u2019s syndrome. Z\u00a0Rheumatol 69(1):41\u201349. https:\/\/doi.org\/10.1007\/s00393-009-0518-3","journal-title":"Z Rheumatol"},{"issue":"11","key":"1305_CR38","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin\u00a0B, Wang\u00a0J, Yang\u00a0Z, Yang\u00a0M, Ma\u00a0N, Huang\u00a0F, Zhong\u00a0R (2015) Epidemiology of primary Sjogren\u2019s syndrome: a\u00a0systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"key":"1305_CR39","doi-asserted-by":"publisher","first-page":"151978","DOI":"10.1016\/j.semarthrit.2022.151978","volume":"53","author":"H Westerlind","year":"2022","unstructured":"Westerlind\u00a0H, Bairkdar\u00a0M, Gunnarsson\u00a0K, Moshtaghi-Svensson\u00a0J, Sysojev\u00a0AO, Hesselstrand\u00a0R, Holmqvist\u00a0M (2022) Incidence and prevalence of systemic sclerosis in Sweden, 2004\u20132015, a\u00a0register-based study. Semin Arthritis Rheum 53:151978. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151978","journal-title":"Semin Arthritis Rheum"},{"key":"1305_CR40","doi-asserted-by":"publisher","first-page":"147997312211255","DOI":"10.1177\/14799731221125559","volume":"19","author":"M Knarborg","year":"2022","unstructured":"Knarborg\u00a0M, Hyldgaard\u00a0C, Bendstrup\u00a0E, Davidsen\u00a0JR, Lokke\u00a0A, Shaker\u00a0SB, Hilberg\u00a0O (2022) Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung disease: a nationwide retrospective cohort study. Chron Respir Dis 19:14799731221125559. https:\/\/doi.org\/10.1177\/14799731221125559","journal-title":"Chron Respir Dis"},{"issue":"1","key":"1305_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semarthrit.2018.11.002","volume":"49","author":"LA Garcia Rodriguez","year":"2019","unstructured":"Garcia Rodriguez\u00a0LA, Gonzalez-Perez\u00a0A, Michel\u00a0A, Saez\u00a0ME (2019) Contemporary epidemiology of systemic sclerosis: a population-based cohort study in the United Kingdom. Semin Arthritis Rheum 49(1):105\u2013111. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.11.002","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"1305_CR42","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","volume":"56","author":"J Svensson","year":"2017","unstructured":"Svensson\u00a0J, Arkema\u00a0EV, Lundberg\u00a0IE, Holmqvist\u00a0M (2017) Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a\u00a0nationwide population-based study. Rheumatology 56(5):802\u2013810. https:\/\/doi.org\/10.1093\/rheumatology\/kew503","journal-title":"Rheumatology"},{"issue":"1","key":"1305_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer\u00a0A, Meyer\u00a0N, Schaeffer\u00a0M, Gottenberg\u00a0JE, Geny\u00a0B, Sibilia\u00a0J (2015) Incidence and prevalence of inflammatory myopathies: a\u00a0systematic review. Rheumatology 54(1):50\u201363. https:\/\/doi.org\/10.1093\/rheumatology\/keu289","journal-title":"Rheumatology"},{"issue":"5","key":"1305_CR44","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","volume":"50","author":"A Sharma","year":"2020","unstructured":"Sharma\u00a0A, Mohammad\u00a0AJ, Turesson\u00a0C (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum 50(5):1040\u20131048. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"1305_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092573","author":"R Redondo-Rodriguez","year":"2022","unstructured":"Redondo-Rodriguez\u00a0R, Mena-Vazquez\u00a0N, Cabezas-Lucena\u00a0AM, Manrique-Arija\u00a0S, Mucientes\u00a0A, Fernandez-Nebro\u00a0A (2022) Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm11092573","journal-title":"J Clin Med"},{"issue":"6","key":"1305_CR46","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/rheumatology\/keab714","volume":"61","author":"R Costello","year":"2022","unstructured":"Costello\u00a0R, McDonagh\u00a0J, Hyrich\u00a0KL, Humphreys\u00a0JH (2022) Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000\u20132018: results from the clinical practice research datalink. Rheumatology 61(6):2548\u20132554. https:\/\/doi.org\/10.1093\/rheumatology\/keab714","journal-title":"Rheumatology"},{"key":"1305_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168331","author":"I Cardoso","year":"2021","unstructured":"Cardoso\u00a0I, Frederiksen\u00a0P, Specht\u00a0IO, Handel\u00a0MN, Thorsteinsdottir\u00a0F, Heitmann\u00a0BL, Kristensen\u00a0LE (2021) Age and sex specific trends in incidence of juvenile idiopathic arthritis in Danish birth cohorts from 1992 to 2002: a nationwide register linkage study. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18168331","journal-title":"Int J Environ Res Public Health"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-022-01305-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-022-01305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T09:03:24Z","timestamp":1699261404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-022-01305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1007\/s00393-022-01305-2","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"18 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Albrecht, S.\u00a0Binder, K.\u00a0Minden, D.\u00a0Poddubnyy, A.C.\u00a0Regierer, A.\u00a0Strangfeld und J.\u00a0Callhoff geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}